Summary

A retrospective “big data” analysis shows that women and men derive a similar survival benefit from both defibrillators and pacemakers. However, women who receive cardiac resynchronization therapy have lower mortality when compared with men. Therefore, strategies must be developed to understand and enhance appropriate utilization of these devices in women.